Proair hfa and Brain neoplasm malignant - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Proair Hfa?
Proair hfa has active ingredients of albuterol sulfate. It is used in asthma. Currently, eHealthMe is studying from 51,358 Proair hfa users.
What is Brain Neoplasm Malignant?
Brain neoplasm malignant (brain cancer tumour) is found to be associated with 583 drugs and 263 conditions by eHealthMe. Currently, we are studying 12,140 people who have Brain neoplasm malignant.
Do you take Proair hfa and have Brain neoplasm malignant?Check whether Brain neoplasm malignant is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Proair hfa side effects by duration, gender and age:
- Proair hfa side effects (51,358 reports)
Brain neoplasm malignant treatments and more:
- Brain neoplasm malignant (12,140 reports)
All the drugs that are associated with Brain neoplasm malignant:
All the conditions that are associated with Brain neoplasm malignant:
How the study uses the data?
The study uses data from the FDA. It is based on albuterol sulfate (the active ingredients of Proair hfa) and Proair hfa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Errin and Dizziness - now
- Promethazine and Feeding Disorder - a second ago
- Carafate and Duloxetine Hydrochloride drug interaction - 4 seconds ago
- Fragmin and Multi-Organ Failure - 14 seconds ago
- Botox and Chills - 19 seconds ago
- Vibramycin and Plaquenil drug interaction - 30 seconds ago
- Implanon and Birth Control - 30 seconds ago
- Acular and Weakness - 48 seconds ago
- Vitamin B3 and Cipro drug interaction - 50 seconds ago
- Cyanocobalamin and Rheumatoid Arthritis - 56 seconds ago